Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol myocardial protection in cardiopulmonary bypass valve replacement
ChiCTR2100045578Phase 4Recruiting
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esmolol in Cardiac valve disease (VHD) (4 arms), sponsored by Yan'an Affiliated Hospital of Kunming Medical University. Primary endpoints: Troponin I, Cardiac ejection fraction and 2 more. Started Jun 2020; status: recruiting.
02
Drugs
esmolol
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2100045578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045578.